Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Trends Cancer. 2018 Feb 21;4(3):176–196. doi: 10.1016/j.trecan.2018.01.003

Figure 5. Patients with Brain Metastasis Eligible for Targeted Therapies.

Figure 5

Patients with lung cancer (A), breast cancer (B), or melanoma (C) brain metastasis may benefrt from targeted therapies. The main oncogenomic alterations that qualify these patients for this advanced treatment are shown, as well as the corresponding drugs that have shown efficacy in the brain. The percentage of patients harboring brain metastases that are susceptible to targeted therapy is very low (D).